...
首页> 外文期刊>Health and technology. >Assessing the uptake, engagement, and safety of a self-management app, COPD.Pal (R), for Chronic Obstructive Pulmonary Disease: a pilot study
【24h】

Assessing the uptake, engagement, and safety of a self-management app, COPD.Pal (R), for Chronic Obstructive Pulmonary Disease: a pilot study

机译:评估自我管理应用程序的摄取,参与和安全性,COPD.PAL(R),用于慢性阻塞性肺部疾病:试点研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chronic Obstructive Pulmonary Disease (COPD) is a widespread condition that accounts for 3 million deaths worldwide annually. Despite being extensive healthcare users, people with COPD (PwCOPD) only spend approximately 1% of their time with a healthcare professional. The rest of the time, they are encouraged to self-manage their condition. To encourage better self-management, Bond Digital Health have created a mobile phone app called COPD.Pal (R) that helps PwCOPD keep track of their condition. This pilot study aimed to assess the safety, engagement, and early efficacy of the app. 25 PwCOPD were recruited and given COPD.Pal (R) for 6-weeks. Healthcare usage, self-management knowledge, app engagement, dyspnoea, and health-related quality of life were measured at baseline and at 6-weeks. A feedback questionnaire was also collected at follow-up. T-tests investigated whether differences between the time points were evident in the data. No statistically significant differences were found between the time points for any of the variables measured. Average app engagement was 31.8 days with 84% using COPD.Pal (R) for 20 or more days during the 6-weeks. 89% of participants stated they would use the app regularly after the study, with 56% stating they'd use it long-term. This study determined that a digital, self-management app would be engaged with and early results indicate that the safety is non-inferior to standard care. Although self-management knowledge remained unaffected by app use, this study provided useful insights regarding how to improve this aspect. This represents one of few studies which involve end-users at an early stage of intervention development, an important strength of the research.
机译:慢性阻塞性肺疾病(COPD)是一种广泛的疾病,每年在全世界造成300万人死亡。尽管是广泛的医疗保健使用者,COPD患者(PwCOPD)只花大约1%的时间与医疗保健专业人员在一起。剩下的时间,他们被鼓励自我管理自己的病情。为了鼓励更好的自我管理,邦德数字健康公司开发了一款名为COPD的手机应用程序。Pal(R)帮助PwCOPD跟踪他们的病情。这项试点研究旨在评估应用程序的安全性、参与性和早期疗效。招募25名慢性阻塞性肺病患者并给予慢性阻塞性肺病治疗。Pal(R)治疗6周。在基线检查时和6周时测量医疗保健使用、自我管理知识、应用参与度、呼吸困难和健康相关生活质量。随访时还收集了反馈问卷。T检验调查数据中时间点之间的差异是否明显。在测量的任何变量的时间点之间,均未发现具有统计学意义的差异。平均应用参与时间为31.8天,84%的人使用COPD。Pal(R)在6周内持续20天或更长时间。89%的参与者表示他们会在研究结束后定期使用该应用程序,56%的参与者表示他们会长期使用该应用程序。这项研究确定将使用一款数字化的自我管理应用程序,早期结果表明其安全性并不低于标准护理。虽然自我管理知识不受应用程序使用的影响,但这项研究为如何改善这一方面提供了有用的见解。这是在干预开发的早期阶段涉及最终用户的少数研究之一,这是该研究的一个重要优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号